Electrophysiological Quality Control of Human Dopaminergic Neurons: Are We Doing Enough?
作者信息
Seutin Vincent
机构信息
Laboratory of Neurophysiology, GIGA Neurosciences, Liège University, Liège, Belgium.
出版信息
Front Cell Neurosci. 2021 Aug 13;15:715273. doi: 10.3389/fncel.2021.715273. eCollection 2021.
Abstract
摘要
相似文献
1
Electrophysiological Quality Control of Human Dopaminergic Neurons: Are We Doing Enough?人类多巴胺能神经元的电生理质量控制：我们做得够吗？
Front Cell Neurosci. 2021 Aug 13;15:715273. doi: 10.3389/fncel.2021.715273. eCollection 2021.
2
Induced dopaminergic neurons: A new promise for Parkinson's disease.诱导性多巴胺能神经元：帕金森病的新希望。
Redox Biol. 2017 Apr;11:606-612. doi: 10.1016/j.redox.2017.01.009. Epub 2017 Jan 16.
3
Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.来自狒狒诱导多能干细胞的多巴胺能神经元的分化与鉴定
Stem Cells Transl Med. 2016 Sep;5(9):1133-44. doi: 10.5966/sctm.2015-0073. Epub 2016 Jun 24.
4
Clinical translation of stem cell transplantation in Parkinson's disease.帕金森病中干细胞移植的临床转化。
J Intern Med. 2016 Jan;279(1):30-40. doi: 10.1111/joim.12415. Epub 2015 Aug 31.
5
Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease.间充质干细胞作为多巴胺能神经元的来源：一种潜在的帕金森病细胞疗法
Curr Stem Cell Res Ther. 2017;12(4):326-347. doi: 10.2174/1574888X12666161114122059.
6
Treatment of Parkinson's disease using cell transplantation.使用细胞移植治疗帕金森病。
Philos Trans R Soc Lond B Biol Sci. 2015 Oct 19;370(1680):20140370. doi: 10.1098/rstb.2014.0370.
7
Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.帕金森病多巴胺能细胞替代和再生策略的研究进展。
ACS Chem Neurosci. 2019 Feb 20;10(2):839-851. doi: 10.1021/acschemneuro.8b00389. Epub 2018 Oct 24.
8
Stem cell therapy for Parkinson's disease: safety and modeling.帕金森病的干细胞治疗：安全性与模型构建
Neural Regen Res. 2020 Jan;15(1):36-40. doi: 10.4103/1673-5374.264446.
9
Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.类器官和多能干细胞在帕金森病模型中的应用：专家对其在药物发现中的价值的看法。
Expert Opin Drug Discov. 2020 Apr;15(4):427-441. doi: 10.1080/17460441.2020.1703671. Epub 2020 Jan 3.
10
Zonisamide promotes survival of human-induced pluripotent stem cell-derived dopaminergic neurons in the striatum of female rats.唑尼沙胺促进人诱导多能干细胞源性多巴胺能神经元在雌性大鼠纹状体中的存活。
J Neurosci Res. 2020 Aug;98(8):1575-1587. doi: 10.1002/jnr.24668. Epub 2020 Jun 7.
本文引用的文献
1
Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use.WNT 信号的双相激活促进了从中胚层诱导多能干细胞向中脑多巴胺神经元的分化，以便用于转化研究。
Cell Stem Cell. 2021 Feb 4;28(2):343-355.e5. doi: 10.1016/j.stem.2021.01.005.
2
Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01.人胚干细胞衍生中脑多巴胺前体细胞产品 MSK-DA01 的临床前疗效和安全性。
Cell Stem Cell. 2021 Feb 4;28(2):217-229.e7. doi: 10.1016/j.stem.2021.01.004.
3
Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease.诱导多能干细胞衍生的多巴胺能祖细胞治疗帕金森病的临床前研究。
Nat Commun. 2020 Jul 6;11(1):3369. doi: 10.1038/s41467-020-17165-w.
4
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.个体化 iPSC 衍生多巴胺祖细胞治疗帕金森病。
N Engl J Med. 2020 May 14;382(20):1926-1932. doi: 10.1056/NEJMoa1915872.
5
Classification of Midbrain Dopamine Neurons Using Single-Cell Gene Expression Profiling Approaches.使用单细胞基因表达谱分析方法对中脑多巴胺神经元进行分类。
Trends Neurosci. 2020 Mar;43(3):155-169. doi: 10.1016/j.tins.2020.01.004. Epub 2020 Feb 11.
6
The future of stem cell therapies for Parkinson disease.帕金森病干细胞治疗的未来。
Nat Rev Neurosci. 2020 Feb;21(2):103-115. doi: 10.1038/s41583-019-0257-7. Epub 2020 Jan 6.
7
Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models.人类自体诱导多能干细胞衍生的多巴胺能祖细胞可恢复帕金森病模型中的运动功能。
J Clin Invest. 2020 Feb 3;130(2):904-920. doi: 10.1172/JCI130767.
8
Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms.多巴胺 D2L 和 D2S 异构体对纹状体运动行为和相关细胞反应的差异调节。
Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):198-203. doi: 10.1073/pnas.1717194115. Epub 2017 Dec 18.
9
Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.人胚胎干细胞衍生多巴胺能神经元治疗帕金森病的临床试验：新时代的曙光。
Cell Stem Cell. 2017 Nov 2;21(5):569-573. doi: 10.1016/j.stem.2017.09.014.
10
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.人诱导多能干细胞衍生的多巴胺能神经元在灵长类帕金森病模型中发挥功能。
Nature. 2017 Aug 30;548(7669):592-596. doi: 10.1038/nature23664.
Zotero 插件